Condition: Prostate Cancer · Sponsor: Lund University Hospital
A randomized phase III trial to study the effect of adding lymph node irradiation in patients with poor prostate-specific antigen (PSA) response during salvage radiotherapy for biochemical recurrence (0.15 ≤ PSA \<0.70 ng/ml) after prostatectomy.
This description comes directly from the study's public registry record.
Adalsteinn Gunnlaugsson, MD, PhD · +46 46 17 75 20 · adalsteinn.gunnlaugsson@skane.se
Jan Sundberg, RN · +46 4617 70 34 · jan.sundberg@skane.se
Always discuss trial participation with your own doctor first.
| Jönköping County Hospital, Ryhov | Jönköping, Sweden | Recruiting |
| Kalmar County Hospital | Kalmar, Sweden | Recruiting |
| Lund University Hospital | Lund, Sweden | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04858880